Fidelity Select Biotechnology Portfolio (FBIOX)
The Fidelity Select Biotechnology Portfolio Fund (FBIOX) primarily invests in common stock, focusing on companies involved in biotechnology research, development, production, and distribution and those benefiting from biotechnology advancements. At least 80% of the assets are invested in these types of companies, both domestically and internationally. Investment decisions are made through a fundamental financial stability analysis, industry position, and market and economic conditions.
Fund Info
| ISIN | US3163907724 |
|---|---|
| CUSIP | 316390772 |
| Issuer | Fidelity |
| Inception Date | Dec 16, 1985 |
| Category | Health & Biotech Equities |
| Min. Investment | $0 |
| Home Page | fundresearch.fidelity.com |
| Asset Class | Equity |
Asset Class Size | Mid-Cap |
Asset Class Style | Growth |
Expense Ratio
FBIOX features an expense ratio of 0.69%, falling within the medium range.
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: FBIOX vs. IBB, FBIOX vs. FXAIX, FBIOX vs. SPY, FBIOX vs. FNCMX, FBIOX vs. FCNTX, FBIOX vs. FSCSX, FBIOX vs. XBI, FBIOX vs. VOO, FBIOX vs. VWIGX, FBIOX vs. FSELX
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Fidelity Select Biotechnology Portfolio, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Fidelity Select Biotechnology Portfolio had a return of 19.13% year-to-date (YTD) and 43.78% in the last 12 months. Over the past 10 years, Fidelity Select Biotechnology Portfolio had an annualized return of 1.31%, while the S&P 500 had an annualized return of 11.39%, indicating that Fidelity Select Biotechnology Portfolio did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 19.13% | 25.48% |
| 1 month | -2.13% | 2.14% |
| 6 months | 13.69% | 12.76% |
| 1 year | 43.78% | 33.14% |
| 5 years (annualized) | 0.75% | 13.96% |
| 10 years (annualized) | 1.31% | 11.39% |
Monthly Returns
The table below presents the monthly returns of FBIOX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 1.51% | 7.90% | 0.92% | -10.56% | 4.72% | 5.33% | 8.26% | 1.53% | -0.33% | -0.09% | 19.13% | ||
| 2023 | 3.19% | -5.00% | -2.07% | 4.41% | 1.41% | 0.30% | 2.17% | -3.30% | -4.88% | -6.60% | 5.22% | 16.92% | 10.09% |
| 2022 | -16.12% | -2.77% | 2.53% | -13.72% | -3.94% | 8.05% | 4.35% | 4.70% | -2.15% | 3.49% | 3.12% | -1.51% | -15.87% |
| 2021 | 0.64% | 0.63% | -5.57% | -6.85% | -5.09% | 6.40% | -2.03% | 5.91% | -5.11% | -1.30% | -6.05% | -6.30% | -23.05% |
| 2020 | -4.44% | -0.43% | -10.37% | 9.76% | 11.15% | 3.97% | -3.65% | 2.96% | 1.65% | -0.50% | 14.89% | -8.30% | 14.36% |
| 2019 | 12.85% | 5.59% | 0.71% | -7.61% | -5.24% | 8.91% | -2.22% | -2.52% | -4.96% | 7.45% | 13.71% | -1.55% | 24.70% |
| 2018 | 9.56% | -2.47% | -3.54% | -6.09% | 7.57% | 0.04% | 1.70% | 5.72% | -1.63% | -15.27% | 3.86% | -16.60% | -19.15% |
| 2017 | 6.30% | 9.84% | -0.83% | 1.15% | -6.64% | 10.93% | 2.64% | 5.34% | 1.98% | -5.90% | 0.09% | 0.08% | 26.06% |
| 2016 | -27.48% | -5.27% | 4.15% | 1.69% | 7.43% | -8.37% | 11.68% | -3.21% | 5.08% | -12.65% | 9.97% | -5.58% | -26.22% |
| 2015 | 6.59% | 5.15% | 3.51% | -5.46% | 11.71% | 2.55% | 2.74% | -10.90% | -12.35% | 6.51% | 6.65% | -0.51% | 13.93% |
| 2014 | 13.11% | 7.75% | -12.02% | -6.77% | 2.65% | 7.41% | -3.42% | 13.17% | -1.32% | 8.31% | 2.54% | 3.53% | 36.68% |
| 2013 | 7.32% | 2.06% | 9.89% | 5.82% | 4.48% | -3.12% | 16.75% | -2.61% | 8.87% | -3.12% | 5.68% | 1.39% | 65.66% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of FBIOX is 45, suggesting that the investment has average results relative to other mutual funds in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Fidelity Select Biotechnology Portfolio provided a 0.68% dividend yield over the last twelve months, with an annual payout of $0.14 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.14 | $0.08 | $0.00 | $0.03 | $0.07 | $0.03 | $0.00 | $0.00 | $0.00 | $1.58 | $2.38 | $0.05 |
Dividend yield | 0.68% | 0.45% | 0.00% | 0.17% | 0.26% | 0.15% | 0.00% | 0.00% | 0.00% | 6.71% | 10.77% | 0.25% |
Monthly Dividends
The table displays the monthly dividend distributions for Fidelity Select Biotechnology Portfolio. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | $0.00 | $0.00 | $0.00 | $0.06 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.06 | |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.08 | $0.08 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 |
| 2020 | $0.00 | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.07 |
| 2019 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.03 | $0.03 |
| 2018 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2017 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2016 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2015 | $0.00 | $0.00 | $0.00 | $0.63 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.96 | $1.58 |
| 2014 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.38 | $2.38 |
| 2013 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.04 | $0.05 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Fidelity Select Biotechnology Portfolio. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Fidelity Select Biotechnology Portfolio was 71.96%, occurring on Jul 10, 2002. Recovery took 2510 trading sessions.
The current Fidelity Select Biotechnology Portfolio drawdown is 28.03%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -71.96% | Mar 7, 2000 | 584 | Jul 10, 2002 | 2510 | Jul 2, 2012 | 3094 |
| -57.97% | Dec 18, 2020 | 349 | May 9, 2022 | — | — | — |
| -45.98% | Jul 20, 2015 | 144 | Feb 11, 2016 | 1215 | Dec 8, 2020 | 1359 |
| -43.63% | Mar 25, 1987 | 154 | Oct 26, 1987 | 503 | Sep 28, 1989 | 657 |
| -36.8% | Jan 15, 1992 | 322 | Apr 8, 1993 | 706 | Dec 22, 1995 | 1028 |
Volatility
Volatility Chart
The current Fidelity Select Biotechnology Portfolio volatility is 5.70%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.